PHCY 830

Introduction to Drug Development.

University of North Carolina at Chapel Hill · UGRD · Fall 2026

1 section

Catalog description

Includes preclinical drug safety evaluation, preclinical pharmacology, design of protocols for Phases I-IV, FDA guidelines for clinical study, preparation of study plan, statistics in clinical trials, data analyzing, and FDA interactions with industry.

Sections

Current meeting, instructor, credit, and enrollment details

Updated 7 hours ago

001

Availability not recently verified

Class #north_carolina_chapel_hill-8110Fall 2026UGRD2 credits

Days & times: No scheduled meeting time
Meeting dates: —
Location: —
Instructor: Staff

Class numbers and section codes come from the registrar.

Spot missing or incorrect course data?